nab-paclitaxel + bleomycin + cisplatin + carboplatin

This is a combination chemotherapy regimen consisting of four cytotoxic agents: **nab-Paclitaxel** is a nanoparticle, albumin-bound formulation of paclitaxel, a taxane that stabilizes microtubules and inhibits cell division. **Bleomycin** is an antitumor antibiotic that induces DNA strand breaks via free radical formation. **Cisplatin** and **carboplatin** are platinum-based compounds that cause DNA crosslinking and apoptosis. This combination brings together multiple mechanisms to maximize cytotoxicity against cancer cells by targeting different aspects of cell division and DNA integrity. Such combinations are studied for synergistic effects in various cancers, including lung, ovarian, breast, and others[1][4][8]. The specific four-drug combination is not standard but components have been used together or in sequence in clinical research settings.

Other names

paclitaxel albumin-stabilized nanoparticle formulation